The Hemorrhagic Coli Pilus (HCP) of Escherichia coli O157:H7 Is an Inducer of Proinflammatory Cytokine Secretion in Intestinal Epithelial Cells by Ledesma, Maria A. et al.
The Hemorrhagic Coli Pilus (HCP) of Escherichia coli
O157:H7 Is an Inducer of Proinflammatory Cytokine
Secretion in Intestinal Epithelial Cells
Maria A. Ledesma
1, Sara A. Ochoa
1, Ariadnna Cruz




3, Jorge A. Giro ´n
4, Juan Xicohtencatl-Cortes
1*
1Laboratorio de Bacteriologı ´a Intestinal, Departamento de Infectologı ´a, Hospital Infantil de Me ´xico Federico Go ´mez, Me ´xico Distrito Federal, Me ´xico, 2Instituto de
Fisiologı ´a Celular, Universidad Nacional Auto ´noma de Me ´xico, Me ´xico Distrito Federal, Me ´xico, 3Departamento de Salud Pu ´blica, Facultad de Medicina, Universidad
Nacional Auto ´noma de Me ´xico, Me ´xico Distrito Federal, Me ´xico, 4Department of Molecular Genetics and Microbiology, Emerging Pathogens Institute, University of
Florida, Gainesville, Florida, United States of America
Abstract
Background: Enterohemorrhagic Escherichia coli (EHEC) O157:H7, the causative agent of hemorrhagic colitis and the
hemolytic uremic syndrome (HUS), produces long bundles of type IV pili (TFP) called hemorrhagic coli pili (HCP). HCP are
capable of mediating several phenomena associated with pathogenicity: i) adherence to human and bovine epithelial cells;
ii) invasion of epithelial cells; iii) hemagglutination of rabbit erythrocytes; iv) biofilm formation; v) twitching motility; and vi)
specific binding to laminin and fibronectin. HCP are composed of a 19 kDa pilin subunit (HcpA) encoded by the hcpA
chromosomal gene (called prepilin peptidase-dependent gene [ppdD]i nE. coli K-12).
Methodology/Principal Findings: In this study we investigated the potential role of HCP of E. coli O157:H7 strain EDL933 in
activating the release of pro- and anti-inflammatory cytokines from a variety of host epithelial cells. We found that purified HCP
and a recombinant HcpA protein induced significant release of IL-8 and TNF-a, from cultured polarized intestinal cells (T84 and
HT-29 cells) and non-intestinal HeLa cells. Levels of proinflammatory IL-8 and TNF-a, but not IL-2, IL6, or IL-10 cytokines, were
increased in the presence of HCP and recombinant HcpA after 6 h of incubation with $50 ng/ml of protein, suggesting that
stimulation of IL-8 and TNF-a are dose and time-dependent. In addition, we also demonstrated that flagella are potent inducers
of cytokine production. Furthermore, MAPK activation kinetics studies showed that EHEC induces p38 phosphorylation under
HCP-producing conditions, and ERK1/2 and JNK activation was detectable after 3 h of EHEC infection. HT-29 cells were
stimulated with epidermal growth factor stimulation of HT-29 cells for 30 min leading to activation of three MAPKs.
Conclusions/Significance: The HcpA pilin monomer of the HCP produced by EHEC O157:H7 is a potent inducer of IL-8 and
TNF-a release, an event which could play a significant role in the pathogenesis of hemorrhagic colitis caused by this
pathogen.
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Introduction
Enterohemorrhagic Escherichia coli O157:H7 (EHEC) causes
infection that range from asymptomatic or mild diarrhea to
hemorrhagic colitis, in some cases causing Hemolytic Uremic
Syndrome (HUS) that may lead to death [1–3]. Several factors
contribute to the virulence of EHEC. Shiga toxins (Stx), also
known as verocytotoxins damage the kidney, renal endothelial
cells and block the microvasculature by toxicity and induction of
local cytokine and chemokine production which leads to renal
inflammation [4].
Interleukin-8 (IL-8) is one of the most important chemokines
and chemoattractants that recruits neutrophils to the site of
infection. Previous studies have shown that some enteropathogens
induce target epithelial cells to produce this cytokine causing only
mild gastroenteritis [5,6]. Shigella infection triggers the production
of IL-8 that can lead to epithelial cell destruction and
histopathologic lesions of the colon [7].
Flagella of many bacterial pathogens are capable of activating
the production of proinflammatory molecules in epithelial,
monocytic, polymorphonuclear, and dendritic cells [8]. Activation
of cytokines such as IL-8, IL-1b, tumor necrosis factor-a (TNF-a)
and IL-6 is triggered by the recognition of flagellin monomers of
many bacterial pathogens via Toll-like receptor 5 (TLR5) (for a
review, see Ref. [9]. For example, the flagellins of EHEC
O157:H7, enteroaggregative and enteropathogenic E. coli strains
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be important in producing the pathologic changes observed in
HUS and together with IL-8 could exhibit synergistic cytotoxic
activity toward human endothelial cells [12]. Gewirtz et al showed
that the flagella of Salmonella enterica serovar Typhimurium triggers
basolateral IL-8 secretion from cultured model epithelia via Ca
++-
mediated activation of the NF-kB pathway [13]. They hypothe-
sized that S. Typhimurium might trigger epithelial exocytosis of a
proinflammatory mediator that could activate IL-8 synthesis via a
mechanism similar to TNF-a [14]. Xicohtencatl et al [8] showed
that purified flagella from Vibrio cholerae and other flagellins (FlaA,
FlaC, and FlaD) found in cell-free supernatants are involved in the
induction of IL-8 in epithelial cells. The two other flagellin
subunits FlaB or FlaE, could not be detected in the supernatants
studied; nevertheless, it is possible that they might be secreted in
the gut environment and have IL-8 induction capability.
IL-8 gene expression is regulated by several pathways and their
promoter region contains binding sequences for diverse transcrip-
tion factors including IL-6, NF-kB and AP-1 [15]. NF-kBi sa
central regulator of the epithelial-cell innate immune response to
infection by enteroinvasive bacteria [16]. AP-1 activation is
dependent on mitogen-activated protein kinases (MAPKs), which
form a group of three signaling pathways, including those for
extracellular signal-regulated protein kinases (ERK1/2) and two
stress-activated protein kinases named p38 and c-Jun N-terminal
kinase (JNK). EHEC O157:H7 is capable of activating expression
of p38 and ERK MAP kinases and the nuclear translocation of the
transcription factor NF-kB [17].
Type IV pili (TFP) are important virulence factors in many
pathogenic Gram-negative bacteria that can mediate adherence to
eukaryotic cells, twitching motility, biofilm formation, DNA
binding and bacterial aggregation [18–24]. The genome of E.
coli O157:H7 contains several loci coding for fimbriae whose
function in in vivo infections remains largely unknown for most of
them [25–27]. Recently, the production of TFP called HCP
(hemorrhagic coli pilus) was reported in EHEC. HCP was shown
to be involved in adherence to epithelial cells and to porcine and
bovine intestinal explants [24], invasion, hemmaglutination,
biofilm formation, twitching motility, and extracellular matrix
glycoprotein binding [28].
The role of HCP in the activation of proinflammatory molecule
expression in epithelial cells has not been explored. In this study
we investigated the role of HCP produced by EHEC O157:H7 in
the activation and release of several proinflammatory and anti-
inflammatory cytokines from human colonic epithelial cells (T84
and HT-29) and non-intestinal HeLa cells. These cells have been
used in the past to study the ability of bacterial products to induce
IL-8 and TNF-a activation [8,10,29,30]. In addition, we evaluated
the activation of MAPK (p38, ERK1/2) and NF-kB signaling
pathways required for the induction of proinflammatory responses
in intestinal epithelial cells. Lastly, we also assessed the role of
flagella as inducer of cytokine production, particularly IL-8 and
TNF-a by epithelial cells during EHEC infection.
Results
Production of HCP by EHEC O157:H7 strain EDL933
To evaluate the production of HCP from EHEC O157:H7, the
EDL933 strain was cultured in CFA agar, Trypticase soy broth
(TSB), Luria Bertani (LB), Mueller Hinton (MH), Dulbecco’s
Minimal Eagle Medium (DMEM) and Minca minimal medium
(Fig. 1A). Our flow cytometry data indicated that 35% of the
EDL933 bacteria grown in Minca were positive for HCP using
anti-HCP (Fig. 1A). The presence of these pili was not detected
when EDL933 was cultured in the other media (Fig. 1A) [24]. In
addition, analysis by Western blot showed that EDL933 produced
HcpA only in Minca and not in the other culture media tested,
confirming the results obtained by flow cytometry (Fig. 1B). The
EDL933 hcpA mutant strain was used as a negative control and did
not cross react with anti-HCP antibodies, which confirmed the loss
of the HcpA protein in this strain (Fig. 1C). To verify that equal
amounts of antigen tested in the Western blot, anti-DnaK
antibodies were used to detect the DnaK protein (Fig. 1B and C).
Immunogold and Purification of HCP and His-tagged
HcpA
Immunoelectron microscopy studies of EDL933 grown in
Minca agar revealed the presence of polar fimbrial structures,
which were recognized by anti-HCP antibodies, confirming the
identity of HCP (Fig. 2A). No reactivity was seen with rabbit pre-
immune serum (data not shown). HCP produced by EDL933 were
obtained after shearing and differential centrifugation, applied
onto a molecular exclusion chromatography column and 0.5-ml
fractions were collected (Fig. 2B). Protein peaks were analyzed by
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) gels stained with Coomassie blue and by Western blotting
using anti-HCP and anti-His-tag antibodies. In the first peak (P1),
as expected, we detected the presence of a protein band with a
molecular weight of 19 kDa, which was identified as HcpA (Fig. 2B
Figure 1. Production of HCP from EHEC EDL933 strain. Flow
cytometry data from the EHEC EDL933 strain cultured in different media
showing optimal production of HCP after bacterial growth in Minca (A).
Western blot confirming HCP production by EDL933 in Minca (B). The
EDL933DhcpA strain was used as a negative control (C). Detection of
DnaK with anti-DnaK antibody was used to ensure that equal amounts
of antigen were tested.
doi:10.1371/journal.pone.0012127.g001
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presence of two proteins of 30 and 14 kDa, respectively (Fig. 2B
and data not shown). The identity of these three protein bands was
assessed using specific antibodies against HCP. Western blotting
experiments showed that the 19-kDa protein found in P1 reacted
with anti-HCP antibodies, confirming the presence of the HcpA
structural subunit of HCP (Fig. 2D). Proteins in peaks P2 and P3,
did not react with anti-HCP antibodies indicating that these
proteins are not related to HCP (data not shown).
The hcpA gene of EDL933 was cloned by PCR and the HcpA
protein was expressed as a fusion protein containing a 66His-tag
at the N-terminus. The His-HcpA protein fusion was purified
under native conditions using imidazole buffer in gradient
concentrations of 100 to 250 mM. The fractions collected showed
two protein peaks (M1 and M2) (Fig. 2B) which showed two bands
of 66 and 22 kDa in 16% SDS-PAGE gels. Western blot analysis
showed that the 22-kDa protein reacted with anti-HCP and anti-
66His-tag monoclonal antibodies whereas the 66-kDa protein did
not react with anti-HCP antibodies (Fig. 2C, D and E and data not
shown). Cleavage of the 66His-tag of the HcpA protein yielded a
19-kDa protein reactive with anti-HCP antibodies (Fig. 2C, and
D). No reaction was observed when this protein was incubated
with anti-66His-tag monoclonal antibodies (Fig. 2E).
HCP Binds to Polarized HT-29 Cells
Studies in vitro indicate that HCP from EHEC O157:H7
mediates adherence to human (intestinal and non-intestinal) and
bovine epithelial cells [24]. We sought to demonstrate direct
binding of purified HCP to the apical surface of HT-29 cells.
Purified HCP used at concentrations of 50, 100, and 200 mg/ml
were incubated with cultured polarized HT-29 cell monolayers
and after removal of unbound pili, HCP bound to the apical
Figure 2. Immunodetection of HCP and the His-tagged HcpA protein. Immunogold-labeling of HCP produced by EDL933 grown on Minca
agar using anti-HCP antibody (A). Scale bars, 0.5 mm. HCP and the HcpA protein (without the His-tag) were purified separately using a molecular
exclusion chromatography (B). Purified HCP and the recombinant protein were depolymerized in 16% SDS-PAGE gels and stained with Coomassie
blue (C). Peak P1, is the highest protein peak that showed a protein of 19 kDa corresponding to the pilus subunit HcpA. Peak M2 obtained during
HcpA-His purification showed a protein that migrated as a 22 kDa protein due to the presence of 6 histidines. Western blot of both proteins with
anti-HCP demonstrated the presence of the pilin (D). Western blot of HcpA His-tagged protein, showing a band of 22 kDa detected with monoclonal
anti-His tag antibodies (E).
doi:10.1371/journal.pone.0012127.g002
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microscopy) using anti-HCP antibodies (Fig. 3A). Dose-dependent
binding of HCP interacting with HT-29 cells was observed
showing an increase of this pilus attached to the surface of the
mammalian cells at high concentrations of protein (Fig. 3A). In
support of these findings, when HCP was pre-incubated for 2 h
with anti-HCP (1:100) antibodies, the interaction of HCP with
HT-29 cells was completely blocked (Fig. 3B). Preimmune serum
used as negative control did not block the interaction of HCP with
HT-29 cells (data not shown). These data suggest that HCP binds
directly to epithelial cells through the recognition of a cell surface-
exposed receptor.
HCP Induced the Activation of Proinflammatory
Cytokines in Polarized HT-29 Cells
Several studies indicate that LPS, flagella, and pili of certain
bacterial pathogens are potent activators of the secretion of a
variety of proinflammatory cytokines [8,10,31,32]. EHEC H7
flagellin, but not the Stx, is the major EHEC factor that directly
upregulates proinflammatory chemokine production by human
colon epithelium in vivo [33]. We investigated the potential role of
HCP as inducer of proinflammatory (IL-2, IL-6, IL-8 and TNF-a)
or anti-inflammatory (IL-10) cytokines from HT-29 human
colonic epithelial cells. Polarized HT-29 cells were incubated with
HCP and HcpA at the apical surface. Analyses of supernatants
collected from the basolateral surface of HT-29 cells indicated that
HCP and HcpA do not trigger IL-2, IL-6, and IL-10 release while
significant high levels of IL-8 and TNF-a were observed (Fig. 4A).
However, when cytokines release at apical surface were tested,
only IL-8 (15% induction) and TNF-a (20% induction) were
detected at the basolateral surface; while IL-2, IL-6, and IL-10
were not detected in the apical surface (data not shown). After a
comparative analysis of the results, we observed that HCP poorly
induced the release of IL-2, IL-6 and IL-10 in comparison to
TNF-a release (1354.33 pg/ml) (P,0.0001) (Fig. 4A). Likewise,
similar results for HcpA were observed when the level of activation
of TNF-a was compared to that of the latter interleukins (Fig. 4A).
The levels of IL-8 and TNF-a release from polarized HT-29 cells
were similar for HCP and the HcpA protein (without the 66His-
tag). When HcpA was analyzed, similar significant differences in
the release of cytokines among IL-8 with the other interleukins
(P,0.001) were obtained (Fig. 4A). In sum, cell-free supernatants
obtained from the basolateral surface of HT-29 cells incubated
with HCP for 6 h, showed low levels of IL-2 (73.66 pg/ml), IL-6
(44.33 pg/ml) and IL-10 (63.66 pg/ml) release compared to IL-8
(1570 pg/ml) release from polarized HT-29 cells (P,0.0001)
(Fig. 4A). The results obtained with HcpA were practically
identical to those obtained with HCP (P,0.001) (Fig. 4A). We also
found that high levels of IL-8 and TNF-a induction were obtained
upon incubation of HT-29 cells with pre-heated pili (monomeric
pilin) and native pili (data not shown). All together, these are
compelling data that support a role for HcpA as a potent inducer
of proinflammatory cytokines.
Cytokines Release in Intestinal and Non-Intestinal Cells
The secretion of IL-8 and TNF-a cytokines was monitored after
6-h incubation of different human polarized colonic (T84 and HT-
29) and non-polarized non-intestinal (HeLa) epithelial cells with
HCP and HcpA. We found that both forms of the proteins activate
the release of IL-8 and TNF-a from the basolateral surface of these
cell lines. The IL-8 release values were slightly higher than those
for TNF-a release (Fig. 4B and C). For example, the levels for
TNF-a for the different cell lines were: 1346.6632.53 (HT-29),
1258.33638.18 (T84), and 1205.3630 pg/ml (HeLa), respectively
(Fig. 4B). These values were significantly higher than those of the
negative control (Fig. 4B). HT-29, T84, and HeLa cells incubated
Figure 3. Binding properties of HCP to HT-29 cells. HCP used at 50, 100, and 200 mg/ml were incubated with polarized HT-29 cells, washed,
and then visualized by IFM (A). Inhibition of HCP binding using a 1:100 dilution of anti-HCP antibodies (B). The nucleus was labeled with propidium
iodide (red) and HCP with Alexa Flour 488 (green). The images were taken at 2006.
doi:10.1371/journal.pone.0012127.g003
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1205.3617.89, and 1223.3625.16, respectively (Fig. 4B).
As shown in Fig. 4C, both HCP and HcpA induced similar levels
of IL-8 release form the 3 cell lines studied. In all, these data strongly
suggest that HcpAand HCPtrigger IL-8 release from thebasolateral
surfaceof these host epithelial celllines and that the monomeric pilin
subunitalone,isresponsiblefortheproinflammatoryactivityofHCP
displayed in host polarized and non-polarized epithelial cells.
Purified flagella from EPEC and EHEC were used as positive
controls to evaluate the release of IL-8 in intestinal cells (HT-29 and
T84 cells) (data not shown). The IL-8 and TNF-a release values
obtained in supernatants collected from the apical surface HCP and
HcpA-treated HT-29 cells were significantly lower (5-fold reduction
for IL-8 and 6.6-fold reduction) for TNF-a compared to those
obtained from the basolateral surface (data not shown).
Concentration and Time-Dependent Induction of IL-8
and TNF-a
HCP and purified HcpA were equally capable of inducing
TNF-a and IL-8 release from HT-29 polarized human colonic
cells in a time and concentration-dependent manner (Fig. 5 and 6).
They induced fast and clear increases in TNF-a release of
approximately ,400 pg/ml at a concentration of 10 ng/ml and
reached a maximum value of ,1400 pg/ml at a concentration of
100 ng/ml of protein (Fig. 5A). The amount of TNF-a released
was a function of the concentration of HCP (Fig. 5B). Detectable
levels of TNF-a were seen after 2 h of incubation and a plateau
was reached at 6 h (Fig. 5). Levels of TNF-a in cell lysates and
supernatants were confirmed by Western blotting with anti-TNF-a
antibodies (Fig. 5B and D). Detection of actin in whole cell extracts
with monoclonal anti-actin antibodies was performed to ensure
that equal amounts of antigen were tested at the different
concentrations and time points. Identical TNF-a release values
were obtained when T84 and HeLa cells were employed (data not
shown).
In parallel, IL-8 induction by HCP and HcpA was tested at
different concentrations of these proteins and during several
incubation-time periods. As for TNF-a, no difference in IL-8
induction was seen between HCP and HcpA. However, IL-8 was
detected only when 25 ng/ml of these proteins were assayed.
These IL-8 detectable levels were obvious starting at 2 h of
incubation reaching a peak at 6 h (Fig. 6A and C). Western blot
analyses of cell lysates and supernatants confirmed the ELISA
results (Fig. 6B and D).
Antibodies Against HCP Blocked Proinflammatory
Cytokines Release
To confirm that HCP induce proinflammatory cytokines (IL-8
and TNF-a) production in intestinal cells, these pili were pre-
incubated for 2 h with anti-HCP antibodies (dilutions 1:200, 1:500
and 1:1,000). We observed a dose-dependent inhibition of IL-8
and TNF-a secretion from HT-29 cells after 6 h of incubation
with the antibodies (Fig. 7A and B). Maximal inhibition (,98%)
was obtained at the 1:200 dilution of the antibody (P,0.0002)
(Fig. 7A and B). When diluted 1:500, a 33–37% reduction for
TNF-a and 36–38% for IL-8 release was observed with both
proteins (Fig. 7A and B). When the dilution was increased to
1:1,000, we observed a poor reduction in TNF-a (7–10%) and IL-
8 (6–8%) release (Fig. 7A and 7B); these three dilutions were
compared with the release of the cytokines without the antibody.
The preimmune serum used as the negative control was not able
to block the IL-8 and TNF-a activation mediated by HCP and
HcpA.
EHEC Infection Increases IL-8 and TNF-a Release in HT-29
Infected Cells
We tested if EHEC infection induces a pro-inflammatory
response from epithelial cells measuring secretion of IL-8 and
TNF-a in conditions where HCP is produced. EHEC strains were
cultured in Minca to stimulate the activation and production of
HCP and other media in which these pili are not produced. In
addition, HT-29 cells were incubated with wild-type EDL933 or
the DhcpA at the apical surface for 6 h. Although IL-8 and TNF-a
levels were the highest when the bacteria were cultured in Minca,
we also detected these cytokines in supernatants of cells infected
with the wild-type and the hcpA mutant pre-grown in CFA, TSA,
LB, MH, and DMEM (data not shown). In all, these data suggest
that other bacterial surface components, in addition to HCP are
present under these growth conditions that promote cytokine
Figure 4. HCP and HcpA selectively activate release of IL-8 and
TNF-a. HCP and HcpA induced release of IL-8 and TNF-a but not IL-2,
IL-6, and IL-10 (A). *P,0.0001 and HcpA **P,0.001. High levels of IL-8
and TNF-a released from HT-29, T84, and HeLa cells in the presence of
HCP and HcpA (B) and (C). HCP and HcpA induced similar levels of IL-8
(1658.3 pg/ml from HT-29; 1558.33 pg/ml from T84; and 1423 pg/ml
from HeLa cells) (C). Both proteins induced comparable levels of TNF-a
release from HT-29, T84, and HeLa cells [HCP (1346.6, 1258.3, and
1205.3 pg/ml) and HcpA (1272.6, 1205.3, and 1223.3 pg/ml)], respec-
tively (B). Polarized intestinal and non-intestinal cells were incubated
alone with DMEM as a negative control.
doi:10.1371/journal.pone.0012127.g004
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residual activity in the hcpA mutant we used a flagella mutant of
EDL933. When the DfliC, and DhcpA/DfliC mutants were
analyzed and compared to the wild-type strain, it was apparent
that both IL-8 and TNF-a levels were mostly reduced in the hcpA/
fliC mutant followed by the fliC and then the hcpA mutant (Fig 8C).
These results demonstrated that both flagella and HCP are potent
inducers of IL-8 and TNF-a proinflammatory cytokines.
HCP Activate NF-kB and AP-1 in HT-29 Intestinal
Epithelial Cells
NF-kB and AP-1 play a central role regulating the activation of
several proinflammatory cytokines such as IL-8, in human
intestinal cells [15,16,34,35]. We performed an Electrophoretic
Figure 5. Induction of TNF-a release by purified HCP. An ELISA-
based assay demonstrating the induction of TNF-a in polarized HT-29
cells in response to different concentrations of purified HCP and HcpA
(A). Western blot showing the kinetics of secreted proteins and cell
lysates produced after the incubation of polarized HT-29 cells with HCP
and HcpA (B). Both proteins stimulate the production of TNF-a in HT-29
cells in a dose-dependent manner. Purified HCP (100 pg/ml) and HcpA
(100 pg/ml) were incubated with polarized HT-29 cells at different
intervals (C). The supernatant recovered from the basolateral surface
showed a significant time-dependent increase of TNF-a as shown by
Western blotting (D). Detection of actin was used as a protein loading
control.
doi:10.1371/journal.pone.0012127.g005
Figure 6. Induction of IL-8 release by purified HCP. IL-8 released
in response to different concentrations of purified HCP and HcpA (A).
Western blot showing the kinetics of secreted proteins and cell lysates
produced after the incubation of polarized HT-29 cells with HCP and
HcpA (B). IL-8 release after 6 h incubation of HCP with HT-29 cells (C).
The supernatant recovered from the basolateral surface showed a
significant time-dependent increase of IL-8 as shown by Western
blotting (D). Detection of actin was used as a protein loading control.
doi:10.1371/journal.pone.0012127.g006
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produced by wild-type EDL933 and its derivative DhcpA mutant to
activate NF-kB and/or AP-1 in polarized HT-29 cells when
incubated for 1 and 3 h. Clear differences were noted at these two
incubation periods. HCP and Minca-grown EDL933 bacteria
showed different percentages of NF-kB and AP-1 activation after
3 h of incubation (Fig. 9A and B). Uninfected cells did not show
NF-kB or AP-1 DNA binding activity (data not shown). We
observed a significant increase of NF-kB and AP-1 activation with
purified HCP and with the wild-type grown in Minca. In contrast,
when the wild-type was cultured in DMEM it showed the same
intensity of NF-kB and AP-1 DNA binding activation compared to
the EDL933DhcpA cultured in DMEM or Minca (Fig. 9A and B).
As a negative control a non-pathogenic E. coli DH5a strain was
used, which showed a slight signal of NF-kB (data not shown). The
analysis by densitometry showed that EHEC infection could lead
to the activation of AP-1 DNA binding activity in similar
percentages to those observed with NF-kB (Fig. 9A and B). The
induction of NF-kB and AP-1 transcription factors is concomi-
tantly activated after 3 h of infection of HT-29 cells with EDL933.
Phorbol myristate acetate (PMA) involved in the transcriptional
activation of AP-1 was used as a positive control (Fig. 9A).
Translocation of NF-kB required the phosphorylation of IkB-a,
which could be analyzed and detected by Western blot using
specific antibodies (Fig. 9F). Phosphorylation of IkB-a was
detected after 3 h of the infection and it was higher when the
Minca-grown EDL933 was cultured in DMEM or the
EDL933DhcpA strain cultured in DMEM or Minca (Fig. 9F).
EHEC Activates MAPK in Human Intestinal Epithelial Cells
The mechanisms of the regulation of AP-1 activity involve
aspects of phosphorylation by members of the MAPK family,
including ERK1/2, p38, and JNK [36,37]. We then determined if
these signaling pathways (e.g. stimulation of MAPK modules)
induce AP-1 activation upon EHEC infection of polarized HT-29
cells. Western blots were performed to evaluate the kinetics of
MAPK activation using specific antibodies that recognize the
phosphorylated forms of ERK1/2, p38 and JNK (Fig. 9C, D, and
E). The active forms of ERK1/2 (p42 and p44), p38, and JNK
(p46 and p54) were not detected in HT-29 cells with or without
1 h of incubation with TNF-a, purified HCP, EDL933 and the
hcpA mutant (data not shown; Fig. 9C, D, and E). Our data showed
that wild-type EHEC expressing HCP triggers hyper-phosphory-
lation of p38 while the EDL933DhcpA mutant does not (Fig. 9D).
When DMEM-grown EDL933 and the hcpA mutant cultures were
used in these experiments similar levels of p38 phosphorylation in
HT-29 cells were observed. ERK1/2 and JNK activation was
detectable only after 3 h of EHEC infection and when incubated
with purified HCP (Fig. 9C and E). Likewise, HT-29 cells infected
with EDL933 pre-cultured in Minca showed increased phosphor-
ylation of p54 and p46, as compared to cells infected with EDL933
and the hcpA mutant harvested from culture conditions in which
HCP is not produced (Fig. 9E). In the case of p44 and p42, no
differences in the level of phosphorylation were observed, although
HCP appears to induce their activation. As control of MAPK
activation in these experiments, HT-29 cells stimulated with
epidermal growth factor (EGF) for 30 min were used (Fig. 9C, D,
and E).
Discussion
The HCP of EHEC O157:H7 displays several biological
functions associated with pathogenicity [24], however, not much
is known regarding its immunobiological properties or the
environmental and nutritional factors involved in the production
of HCP. In many instances, in vitro growth conditions constitute
signals that may typify or mimic certain biological niches.
Environmental signals and molecular mechanisms are typically
involved in regulation of virulence gene transcription, for example
the Stx of EHEC, the toxin-coregulated pilus from V. cholerae, the
bundle-forming pili (BFP) from EPEC, and the 987P pili of
enterotoxigenic E. coli (ETEC) [38–42]. We previously reported
production of HCP by EHEC O157:H7 after growth in Minca
minimal media [24]. The fact that HCP is produced only in Minca
and not in nutrient rich media or tissue culture medium is an
indication that, like other E. coli fimbriae, expression of HCP genes
is tightly regulated by nutritional signals. Minca medium has been
used in the past to successfully induce expression of fimbriae in
bovine ETEC [43]. It is possible that a yet unknown signal(s) is
present in this medium that relieves the negative regulation of
fimbrial genes exerted in other growth conditions. HCP are also
produced upon contact of EHEC with cultured epithelial cells and
explants of pig intestinal tissue suggesting that production of these
pili is stimulated also by host signals [24].
Purified HCP bound specifically to cultured mammalian cells
most likely via a yet unknown receptor and antibodies against
Figure 7. Anti-HCP antibodies blocked the secretion of
proinflammatory cytokines. Purified HCP or HcpA protein
(100 pg/ml) were pre-incubated with anti-HCP antibodies in DMEM
low glucose medium before addition to the apical surface of HT-29
cells. A dose-dependent inhibition for IL-8 and TNF-a from HT-29 cells
was obtained: between 95–98% at the 1:200 dilution of the antibody (A
and B). *P,0.0002.
doi:10.1371/journal.pone.0012127.g007
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HCP has adhesive properties [24]. The fact that HCP-producing
strains are highly adherent to intestinal, non-intestinal and bovine
cells suggests the presence of a common receptor in these cell lines
[24].
Pathogen-associated molecular patterns (PAMPs) such as LPS,
flagella, and pili are potent activators involved in the secretion of a
variety of proinflammatory cytokines [8,10,31,32]. Bacterial
flagellins are potent inducers of proinflammatory molecules (IL-
1b, IL-6, and IL-10) via TLR5 in epithelial cells [45,46]. There is
a growing interest in IL-8 and TNF-a as powerful neutrophil
chemoattractants and activators. EHEC infections in humans are
characterized by the presence of inflammation of the colon or
hemorrhagic colitis [47]. E. coli O157:H7 strains produce virulence
factors that contribute to the proinflammatory and immune
responses of intestinal cells to this pathogen [14,44]. Previous in
vivo and in vitro EHEC infection studies demonstrated that the
production of Stx induces an inflammatory response attributed to
Figure 8. Comparison of the IL-8 release induced by EDL933 and derivative mutants after growth in different media. The highest level
of IL-8 and TNF-a release was observed after growth of EDL933 in Minca (A and B) (*P,0.0001). The hcpA mutant was reduced for IL-8 and TNF-a
induction compared to the wild-type strain (**P,0.0012). Comparison of IL-8 and TNF-a induction by EDL933, EDL933DhcpA, EDL933DfliC and
EDL933DhcpA/DfliC previously cultured in Minca (C). Asterisks and ampersands indicate that a value is significantly different from the value for the
mutant in hcpA, fliC and the double mutant hcpA/fliC cultured in Minca, **P,0.0012,
&&P,0.005, ***P,0.001, and **** P,0.0001.
doi:10.1371/journal.pone.0012127.g008
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PLoS ONE | www.plosone.org 8 August 2010 | Volume 5 | Issue 8 | e12127Figure 9. EHEC infection induced AP-1, NF-kB DNA binding, MAPK and IkB-a activation in HT-29 cells. Infection with purified HCP, wild-
type O157:H7 and the hcpA mutant showing percentages of AP-1 activation; PMA: Phorbol myristate acetate (A). Infection with purified HCP, wild-
type O157:H7 and the hcpA mutant showing percentages of NF-kB activation (B). Western blot showing the kinetics of MAPK activation using specific
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act as mediators of IL-8 secretion by intestinal cells. We sought to
explore the contribution of HCP to the genesis of gut
inflammation by measuring its potential as an inducer of
proinflammatory cytokines in macrophages and epithelial cells
(intestinal and non-intestinal) in response to infection. We found
that host cells incubated with HCP or infected with EHEC
O157:H7 are activated for the release of IL-8 and TNF-a, and
phosphorylation of p38, ERK1/2 MAP kinases, and NF-kB.
Several signaling pathways regulate the expression of the IL-8
gene [44]. In comparison to EPEC flagellin, which was previously
shown to induce IL-8 release from T84 cells [10], HCP stimulated
higher levels of IL-8 release from HT-29 cells. Dosage and kinetics
studies showed that activation of IL-8 and TNF-a release dose and
time-dependent. We also observed increased AP-1 DNA binding
activity after 3 h of EHEC infection in conditions where HCP is
produced. No differences in AP-1 DNA binding were observed
between suboptimal conditions of HCP production or when the
hcpA mutant was used. Our data also showed that HCP induced
the activation of the NF-kB factor in HT-29 cells. Multiple
signaling pathways may converge to activate NF-kB in epithelial
cells stimulated by pathogenic E. coli [49,50], S. Typhimurium,
Shigella flexneri, Helicobacter pylori, or EPEC [13,34,51,52]. Previous
studies showed that the activation of three main members of the
MAPK family (ERK1/2, p38, and JNK) is stimulated by the
presence of EHEC in Caco-2 and T84 cells [53]. In agreement
with these studies, we found that HCP-producing EHEC may
stimulate the activation and phosphorylation of p38, ERK1/2 and
JNK possibly by IL-8 activation.
The flagellins of Salmonella spp. [54–56] and other Gram-
negative bacteria share similar inflammatory properties suggesting
that some degree of sequence or structure conservation which is
responsible for inflammatory response induction [57]. The HcpA
monomer alone is capable of inducing cytokines release. It remains
to be determined what specific sequences of the HcpA protein
contribute to the eukaryotic proinflammatory activity demonstrat-
ed here. Based on our findings, we conclude that HCP along with
LPS and flagella could be responsible for the inflammatory
processes undergone during hemorrhagic colitis.
Materials and Methods
Bacterial Strains and Growth Conditions
To evaluate the production of HCP EHEC O157:H7 strain
EDL933 was cultured in different media [Colonization factor
antigen (CFA) agar, Trypticase soy broth (TSB), Luria Bertani
(LB) broth, Mueller Hinton (MH), Dulbecco’s minimal Eagle
medium (DMEM), and Minca minimal medium broth] with
shaking, at 37uC and 5% CO2. Minca minimal medium contained
1.36 g KH2PO4, 10.1 g Na2HPO4.2H2O, 1 g glucose, 1 g
casaminoacids, 10 g MgSO4.7H2O, 1 g MnCl2.4H2O, 0.135 g
FeCl3.6H2O, 0.4 g CaCl2.2H2O per liter adjusted to pH 7.5 and
1.5% agar [43].
DNA Manipulations
Restriction enzyme digestion, agarose gel electrophoresis, PCR,
plasmid extraction, DNA ligation, bacterial transformation and
other routine DNA procedures were performed as described by
Sambrook et al [58].
Construction of Isogenic Mutants
Non-polar deletion mutants in hcpA, fliC, and hcpA/fliC genes
were generated by the lambda Red recombinase method, as
previously described [59]. The mutation of the hcpA gene in
EDL933 was constructed replacing it with a kanamycin-resistance
cassette derived from the template plasmid pKD4. The primers
used for the mutagenesis of the hcpA gene were G68 hcpA/P1 (59-
AATCAAGGAGCGAAACAGATGGACAAGCAACGCGGTT-
TTA C ATGTAGGCTGGAGCTGCTTCG-39) and G69 hcpA/
P2 (59AATATTCATTGCCGCTCC TTAGTTGGCGTCAT-
CAAAGCGGAACATATGAATATCCTCCTTAG-39). The hcpA
mutation was confirmed by selecting colonies grown in LB with
kanamycin and by PCR using primers G98 hcpA-F (59TCG-
CTAGTTGCTGACAGATTT-39) and G99 hcpA-R (59-AA
TGTCTGTTGTGTGCGACTG-39), as previously described by
Xicohtencatl-Cortes et al [24]. In addition, a chloramphenicol
antibiotic-resistance gene amplified from pKD3 using forward
primer G72 (59-AATATAGGATAACGAATCATGGCACAAG-
TATTAATACCAA CTGTAGGCTGGAGCTGCTTCG-39)a n d
reverse primer G73 (59-TTAATCAGGTTACAA CGATTAA-
CCCTGCAGCAGAGACAGAACCATATGAATATCCTCCTT -
A-39) was introduced in the chromosomal fliC gene as previously
described by Erdem et al [60]. Mutants were grown on selective media
and the fliC mutation was confirmed by PCR using primers G94 (59-
TCCC AGCGATGAAATACTTGC-39)a n dG 9 5( 5 9-GAGT-
TATCGGCATG ATTATCC-39). EDL933 was grown overnight in
LB broth at 37uC with shaking, unless otherwise stated. Arabinose was
used at a concentration of 100 mM in LB broth to induce l Red
recombinase production from plasmid pKD46 [59]. Antibiotics used in
selected media were used at the following final concentrations:
kanamycin (100 mg/ml), chloramphenicol, (30 mg/ml), and ampicillin
(100 mg/ml).
Cloning and Expression of His-tagged HcpA
The hcpA gene of EDL933 was PCR-amplified with the forward
primer hcpA-F (59-C CGGGATCCTTTACACTTATCGAACT-
GAT-39) and reverse primer hcpA-R (59-GCCAAG CTTTT-
AGTTGGCGTCATCAAA-39) and cloned into the pET-28
plasmid (Novagen) yielding a recombinant fusion protein with
histidine (66His) and T7 tags at the amino terminus.
Antisera
Rabbit anti-PpdD antibody referred to as anti-HCP was a kind
gift from O. Francetic (Pasteur Institute) and was used after 66
adsorptions with the EDL933 hcpA mutant strain to remove non-
specific antibodies [24].
Immunogold Labeling and Purification of HCP and His-
tagged HcpA
For immunoelectron microscopy, bacteria were incubated with
anti-HCP serum diluted 1:10 in PBS containing 1% (w/v) bovine
serum albumin (BSA) for 2 h and washed three times with PBS.
Goat anti-rabbit IgG labeled with 10-nm gold particles (Sigma-
Aldrich) diluted 1:10 in PBS-BSA was used to detect antibodies
bound to the pili and was incubated for 2 h at room temperature.
After washing with PBS, the samples were negatively stained with
1% sodium-phosphotungstic acid (pH 7.4) for 5 min and then
visualized under a Philips transmission electron microscope (TEM).
antibodies that recognize the phosphorylated forms of p42 and p44 (C). Wild-type EHEC is involved in the p38 phosphorylation in conditions where
HCP is produced and a significant decrease was observed when tested with the EDL933 hcpA mutant (D). ERK1/2 and JNK activation were detectable
after 3 h of EHEC infection (E). IkB-a activation was detectable after 3 h of EHEC infection (F). * EDL933 O157:H7 and ** EDL933DhcpA.
doi:10.1371/journal.pone.0012127.g009
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Minca media plates (150615 mm) with 1.5% agar, incubated and
grown for 24 h, at 37uC and 5% CO2. The bacteria were
resuspended in 100 mM phosphate buffer, pH 7.4 and the pili
were detached by vigorous shaking. The different steps of the HCP
purification procedure were monitored by TEM, sodium dodecyl-
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and
Coomassie blue staining, as previously described [21]. Briefly,
bacteria were separated by centrifugation at 10,0006g for 30 min
and the supernatant was centrifuged at 18,0006g for 30 min to
remove flagella, outer membranes and bacterial debris. The pili-
containing supernatant was centrifuged at 78,0006g for 2 h and
the pellet was dissolved in 5 ml phosphate buffer 100 mM and
pH 7.4. The suspension containing HCP was applied onto a
molecular exclusion chromatography column (Sephadex G-100;
Sigma- Aldrich) and the pili were eluted in 0.5 ml fractions with
100 mM sodium phosphate buffer (pH 7.4), and read at OD280
nm.
The purification of recombinant HcpA protein was performed
according to the manufacturers’ procedures (Qiagen). After
binding of HcpA-66His to the nickel column, 20 mM imidazole
was used to remove contaminant proteins and the HcpA
recombinant protein was eluted with a gradient of 100 to
250 mM of imidazole. The 66His was removed from HcpA
using the procedure described in the Qiagen protocol. HcpA
without the 66His-tag was dissolved in 100 mM phosphate buffer,
pH 7.4 and applied onto a molecular exclusion chromatography
column (Sephadex G-10; Sigma-Aldrich). Fractions of 0.5 ml were
collected and protein content monitored at OD 280 nm. Protein
peaks were analyzed by 16% SDS-PAGE stained with Coomassie
blue and by Western blotting. To remove LPS (endotoxin), the
HCP and HcpA were mixed with polymixin B beads (Sigma-
Aldrich) and as previously described [61].
SDS-PAGE and Western Blot Analyses
HCP and HcpA were routinely separated by SDS-PAGE on
16% acrylamide gels and stained with Coomassie blue. For
Western blotting, the proteins were transferred onto a PVDF
membrane for 2 h at 90 volts. The immobilized proteins were
incubated 1 h with a primary antibody against HCP with a
dilution of 1:3,000 at room temperature. After washing three times
with PBS-Tween-20, the membrane was incubated 1 h with goat
anti-rabbit IgG conjugated to peroxidase (Sigma-Aldrich). The
blots were developed with HyGLO chemiluminescent HRP
antibody detection reagent (Amersham) [24]. For the detection
of His-tagged HcpA, a mouse monoclonal anti-His antibody
(Sigma-Aldrich) was used.
Quantification of HCP by Flow Cytometry
To determine the production of HCP by flow cytometry,
EDL933 strain was cultured in different media [CFA agar, TSB,
LB, MH, DMEM, and Minca minimal medium] at 37uC with 5%
CO2, as previously described [24]. For the assays, 45 ml of each
bacterial culture with an optical density of 1.1 were incubated with
40 ml of anti-HCP (1:2,000) for 2 h. Then, three gentle washes
were performed with cold PBS and incubated for 2 h with 40 mlo f
a 1:10,000 dilution of goat anti-rabbit IgG (H+L) Alexa Fluor
conjugate (Invitrogen, California, USA) and resuspended with
800 ml (final volume) of PBS. Bacteria were labeled with 5 mlo fa
propidium iodide solution (Sigma-Aldrich) and analyzed in a
Becton Dickinson FACS Calibur. The experiments were per-
formed three times by triplicate on separate days and the data
were expressed as the mean of the averages.
Binding of Purified HCP to HT-29 Cells
To determine if HCP have adhesive properties, 50, 100, and
200 mg/ml of purified HCP were applied on the apical surface of
polarized HT-29 cells present and incubated for 2 h at room
temperature, washed with PBS, and then fixed with 2%
formaldehyde. After washing 3 times with PBS, propidium iodide
was added to stain the nucleus of the eukaryotic cells and bound
HCP was detected with anti-HCP (1:3,000) serum followed with
secondary anti-rabbit Ig antibody conjugated to Alexa-Fluor 488
(1:10,000). To confirm the results a binding inhibition assay was
performed, in which HCP was pre-incubated with a 1:100 dilution
of anti-HCP antibodies for 2 h before its addition to the HT-29
cells. In both cases, the samples were processed and monitored by
immunofluorescence microscopy (IFM).
Induction of Proinflammatory Cytokines in Intestinal and
Non-Intestinal Cells
Polarized epithelial cell monolayers (HT-29 and T84) and non-
polarized epithelial cells (HeLa) were maintained at 1:1 mixture of
DMEM/Ham’s F12 medium (GIBCO BRL)], supplemented with
10% fetal bovine serum (Invitrogen, California, USA), 2 mML -
glutamine, 1.5 g/l sodium bicarbonate, 10 mM Hepes buffer,
0.1 mM non-essential amino acids, 1.0 mM sodium piruvate
(90%), 40 mg/ml penicillin and 90 mg/ml streptomycin. Mono-
layers of intestinal cells were polarized and maintained at 37uC
and 5% CO2. The monolayers of intestinal and non-intestinal cells
were incubated with protein (HCP and HcpA) in the apical surface
at various concentrations (0.1, 1, 10, 25, 50, 75, and 100) and at
different times (0.5, 1, 2, 4, 6, 12, and 24 h) to evaluate the
triggering of cytokines. The culture supernatants were collected
from the apical and basolateral surfaces, centrifuged for 10 min at
10,0006g (to remove outer membranes and cell debris) and filter
sterilized using 0.22-mm-pore-size filters to be analyzed by ELISA
[10]. Supernatants obtained from HeLa cells were also filter
sterilized using 0.22-mm-pore-size filters. The medium employed
for the preparation of epithelial cells and purified flagella from
EPEC and EHEC, was used as negative and positive controls,
respectively.
The induction of proinflammatory cytokines by the EDL933
O157:H7 and derivative mutants hcpA, fliC and hcpA/fliC was also
analyzed by ELISA, after grown in Minca media. Likewise, the
wild-type and the hcpA mutant were also used to study the
induction of proinflammatory cytokines in different media.
Transepithelial Electrical Resistance Measurements
Colonic intestinal epithelial HT-29 and T84 cells were
maintained in the same medium as described above. Polarized
epithelial cell monolayers were prepared by seeding 5610
5 cells on
Transwell-Clear polyester membranes (3-mm-pore-size, 6.5-mm-
diam Costar inserts; Costar Corp.) as previously described [10].
Integrity of tight junctions was monitored by transepithelial
resistance to passive ion flow with a dual voltage ohmmeter
(Millicell-ERS; Millipore Corp.). The polarized T84 and HT-29
cells were not used until the transepithelial resistance of the
monolayers reached between 1,500–2,000 V/cm
2 or higher.
Quantification of Proinflammatory Cytokines by ELISA
A sandwich ELISA using 96-well plates coated overnight at
4uC, and using a concentration of 10 mg/ml goat anti-human
antibodies of IL-8 and TNF-a (BD Biosciences Pharmingen, San
Diego, CA, USA) was performed as previously described [8]. The
supernatants obtained from the apical and basolateral surfaces
after 0.5, 1, 4, 6, 12, and 24 h of incubation of HCP with intestinal
HCP in EHEC O157:H7
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anti-human IL-8 and TNF-a. In different experiments levels of IL-
8 and TNF-a were measured in supernatants of intestinal cells
incubated with 0.1, 1, 10, 25, 50, 75, and 100 ng/ml of HCP. The
complexes were detected with goat anti-rabbit IgG peroxidase
conjugate (Sigma-Aldrich, St. Louis, MO, USA) and peroxidase
substrate. Color development was read at an optical density of
595 nm.
The detection of the release of other interleukins such as IL-2,
IL-4, IL-6 and IL-10 present in the supernatants of the apical and
basolateral surfaces, were also measured after 6 h of incubation
with 100 ng/ml of purified HCP and the cytokines were detected
by ELISA as described above. The IL-2, IL-6, and IL-10 release
was detected with monoclonal antibodies (anti-IL-2, anti-IL-6 and
IL-10, respectively) (Santa Cruz Biotechnology, Inc.). All deter-
minations of cytokines were performed by triplicate.
Blocking Cytokines Release in HT-29 Cells
To confirm that HCP and HcpA induce proinflammatory
cytokines (IL-8 and TNF-a) production in intestinal cells, HCP or
HcpA were incubated at 37uC for 2 h with rabbit polyclonal
antibodies against HCP and then were added to the apical surface
of polarized HT-29 cells for 6 h. Cytokines were assayed as
described above.
Electrophoretic Mobility Shift Assay (EMSA)
Polarized HT-29 cells were seeded into six-well plates. The cell
monolayers were washed and treated with EHEC EDL933 and
the hcpA mutant in serum- and antibiotic-free DMEM. At the
times indicated below, the infected cells were washed with PBS.
AP-1 and NF-kB DNA binding activities were analyzed and
prepared as described by Dahan et al [44]. Oligonucleotide probes
contained the consensus sequence for AP-1 site (59-TTC-
GTGACTC AGCGG-39) and for the NF-kB site (59-ATGT-
GAGGGGACTTTCCCAGGC-39). The specificity of the com-
plexes was analyzed by incubation with an excess of unlabeled
AP-1 or NF-kB oligonucleotides. Complexes were separated by
electrophoresis on a 6% non-denaturing polyacrylamide gel in
0.56 Tris-borate-EDTA buffer. The dried gels were autoradio-
graphed (Amersham Hyperfilms).
HT-29 cells obtained after the infection were washed with PBS
and scraped at 4uC with a lysis buffer described by Dahad S. et al
[44]. The cells were sonicated and solubilized for 30 min at 4uC,
and then centrifuged at 14,0006g for 20 min at 4uC. The protein
concentration of the supernatant was determined by the Bradford
method. Equal amounts (50 mg) of whole-cell lysates were subjected
to 16% SDS-PAGE gels and the proteins were transferred
to a PVDF membrane. After blocking with 5% milk, they
were incubated overnight at 4uC with anti-phospho-ERK1/2,
anti-phospho-p38, anti-phospho-JNK, anti-phospho-IkB-a,a n d
anti-IkB-a rabbit antibodies (New England Biolabs) or with anti-
ERK2, anti-p38, anti-JNK (Santa Cruz Biotechnology, Santa Cruz,
Calif.) and horseradish peroxidase-conjugated anti-rabbit antibod-
ies. The presence of antibodies was revealed with the enhanced
chemiluminescence detection system.
Densitometric Analysis
The changes in signal or band intensity were quantified by
densitometric analysis using the Quantity One 4.4.1 program (Bio-
Rad chemi-doc). All experiments were repeated at least three times
and a representative result is shown for each experiment.
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